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THE ILLINOIS PRESCRIPTION DRUG PLAN: WILL IT
LAST? AN ANALYSIS OF THE CURRENT STATE OF
HEALTH CARE, CONGRESSIONAL EFFORTS TO
LOWER PRESCRIPTION DRUG COSTS, AND
ILLINOIS' RESPONSE TO HIGH PRICES.
Jennifer Micheletto
I. INTRODUCTION
Low-cost prescription drugs and the efforts to import them have been a
hot political topic for quite some time. In 2000, voter polls indicated
that low-cost prescription drug coverage was a key political issue.1 In
2004, both presidential candidates, in response to the polls, made drug
importation central to their platforms and vowed to seriously consider
2the issue if elected. However, the Food and Drug Administration
(FDA) has taken a strong stance against importation, stating that the
safety of such imports is questionable. 3  Private companies have
attempted to import prescription drugs; however, the government has
successfully quashed such efforts.4 Acknowledging the need for lower
cost prescription medications, state governments have begun
establishing means of importation with the hopes of saving its citizens
a significant sum of money. 5 Most recently, the Illinois plan, I-Save
Rx, has gained public attention. 6  Unlike litigation against private
entities, however, the FDA, at present, has not taken action against the
Illinois program.7 This paper will examine the viability of the Illinois
prescription drug plan. Part II of this article will discuss the current
state of health care in the United States. Specifically, Section II will
examine general health care statistics, the pharmaceutical industry, and
the contrasting Canadian pharmaceutical regulations. , Section III will
analyze the United States Federal Government's views regarding drug
' Dan Balz, 2004 Presidential Election: Voter Drives Reshaped Electorate, Creating
Uncertainty on Turnout, WALL ST. J. EUR., Oct. 25, 2004, at A14,
2 Editorial, Imported Drugs Study: A Report that Resolves Little, PHILA. INQUIRER,
Dec. 26, 2004, at C06
3id.
4 See, e.g., U.S. v. Rx Depot, 290 F.Supp.2d 1238 (N.D. Okla. 2003).
5 Lynn Sweet, Illinois Defying Feds, Importing Rx Drugs; But FDA is Threatening to
Take State to Court; CHI. SUN-TIMES, Aug. 17, 2004, at 8.
6id.
7Id.
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importation. Section IV will discuss significant cases involving private
actions against companies importing prescription drugs. In Section V,
various states' importation programs will be discussed. Section VI will
analyze the viability of Illinois' I-Save Rx program.
II. CURRENT STATE OF HEALTH CARE IN THE
UNITED STATES
A. Uninsured Americans
Statistics indicate that at any one time, more than 43 million people in
United States under 65 years of age have no health insurance. 8 In a
2000 study of the effectiveness of health care systems throughout the
world, the World Health Organization ranked the United States thirty-
seventh.9 Interestingly, however, the United States spends 15% of its
gross domestic product, more money than any other country in the
world, on health.10 The large expenditure continues to grow and
ultimately results in higher health costs for Americans. In 1998,
private-sector companies were spending $1 per hour for each employee
for health care coverage. 1 In 2003, the cost of health care coverage for
private-sector employees had risen to $1.50. 12 As a result of this
significant increase, more employers are cutting health insurance for
their employees, thus adding to the number of uninsured workers in
America. 13  Without health insurance, these Americans also lack
prescription drug coverage. Individuals with no prescription drug
coverage pay full price for their expensive prescriptions. 14
Paying out-of-pocket for prescription drugs, however, is not
unique to the uninsured. Millions of Americans who do have health
insurance do not have prescription drug coverage as part of their plan,
thus forcing this group of people to also directly pay the high cost of
prescriptions. 15  Additionally, even Americans who do have
8 Headaches for All, ECONOMIST, Oct. 9, 2004, at 22.
9Id.
10 Id.
11 Id.
12 id.
13 Headaches for All, supra note 8.
14 UNITED STATES PUBLIC INTEREST RESEARCH GROUP, PAYING THE PRICE: THE HIGH
COST OF PRESCRIPTION DRUGS FOR UNINSURED AMERICANS 4 (2004), available at
http://www.uspirg.org/reports/payingtheprice.pdf (last visited Feb. 1, 2006)
[hereinafter PAYING THE PRICE].
15 Id.
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prescription drug coverage are forced to pay a "portion of the
discounted price negotiated by their insurance company."' 6  Many
prescription drug plans still require the consumer to "make large co-
payments or spend somewhere between $100 and $500 in deductibles
before covering most services."
' 17
B. Public Opinion
The public has voiced its discontent with the state of health care in the
United States, and prescription drug coverage is a significant concern
with the current system.' 8 An Associated Press poll "found that nearly
two-thirds of those surveyed said the government should make it easier
to buy cheaper drugs from Canada and other countries." 19 Yet, even
with such strong public support, federal legislators have yet to pass a
bill permitting such importation, and the current administration has
20vehemently opposed such importation.
C. The Pharmaceutical Industry in the United States
The American pharmaceutical industry leads the world in the
production of new drugs. 21 American producers, between 1970 and
1992, accounted for approximately 43 percent of the new prescription
drugs on the market, while Britain, Germany, and France accounted for
14 percent, seven percent, and three percent, respectively.
22
Additionally, from 1975 to 1989, the United States produced 47 new
16 Id.
17 Id.
18 Bush Team's Report Opposes Imported Drugs, ST. LOUIS POST-DISPATCH, Dec. 22,
2004, at A4 [hereinafter Imported Drugs].19 Id.
20 Id. See Amanda Gardner, Support for Canadian Drug Imports Hits Groundswell,
HEALTHDAY. Nov. 24, 2004, available at
http://ww3.komotv.com/Global/story.asp?S=1847873 (last visited Apr. 26, 2006).
This article notes that despite a slight change in viewpoint from Tommy Thompson in
the Department of Health and Human Services, the Bush Administration is
"staunchly-and aggressively-adamant in its opposition to legalizing the
importation of drugs from Canada. The administration and the pharmaceutical
industry cite safety concerns as the key to their opposition." Id..
21 Andrew Harris, Recent Congressional Responses to Demands for More Affordable
Pharmaceuticals; 16 LoY. CONSUMER L. REV. 219,-219 (2004).
22 Id. See Relieffor the Drug Giants in No-Change Decision, EVENING STANDARD,
Nov. 3, 2004 at A37 (stating that the U.S. pharmaceutical industry is worth $340
billion, making it the most "lucrative in the world.").
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drug products while the rest of the world produced a combined total of
50.23 These statistics indicate the important role of the pharmaceutical
industry in the United States.
Yet, despite such leading efforts and production, prescription
drugs in the United States are far more expensive than in Canada and
the rest of the world.24 The already high prices continue to rise. In
1999, for example, "prices for prescription drugs increased by a record
17.4% over the previous year.",25 Some studies indicate that "many
brand-name drugs are at least one-third cheaper in Canada and
elsewhere. 26  Researchers have given several reasons for this price
discrepancy. First, prescriptions in the United States are "not set
according to a normal supply and demand scheme, and except for a few
limited controls, drug prices are largely unregulated., 27  Drug
companies have complete discretion in setting prices at whatever level
they desire.28 Logically, one can deduce that the manufacturer, seeking
to make a substantial profit, will set the levels quite high.29
The drug companies claim that the high prices are necessary in
order to continue a high standard of research and development.3 ° The
numbers indicate that the "brand-name pharmaceutical manufacturers
spent more than $30 billion on research in 2001.31 While drug
companies claim that the high research costs are necessary in order to
develop new prescriptions, independent studies of the industry indicate
that the "industry has not introduced many new and innovative drugs to
the market in the last decade. 32 Of the new drugs actually produced,
65% of the FDA-approved drugs from 1989 - 2000 were composed of
ingredients found in prescriptions already on the market. 33 Research
23 id.
24 PAYING THE PRICE, supra note 14, at 5. Uninsured Americans pay nearly twice as
much for prescription drugs as Canadians. Additionally, Americans pay nearly 105%
higher price for the nine of the most common prescriptions. Id.
25 Harris, supra note 21, at 219.
26 Imported Drugs, supra note 18.
27 Todd Rosenfield, The Counterfeit Drug Invasion: How Drug re-Importation
Unjustifiably Poses a Threat to the Health of the U.S. Public, 25 U. PA. J. INT'L
ECON. L. 1047, 1049 (2004).
28 Id.
29 id.
30 id.
31 Farin Khosravi, Price Discrimination in the United States: Why are
Pharmaceuticals Cheaper in Canada and are Americans Seizing the Opportunities
Across the Border?, 9-SPG L. & Bus. REV. AM. 427, 429 (2003).
32 Id.
33 id.
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indicates that, in actuality, drug companies only spend 11% of their
revenue on the research and development of new drugs. 
34
Patents are another reason why drug prices remain high in the
United States. Drug companies claim that patents are a necessity in
order to keep the company viable, and to invest the profit from the
protected product in future research and development. 35  Patents,
however, enable the drug companies to have a monopoly over the
product markets. 36 When a patent expires, cheaper generic drugs cause
the price of the drug company's original product to significantly drop.
37
Therefore, drug manufacturers, upon producing a new product, seek a
patent to protect their property, 38 and such a patent keeps other
companies from producing a comparable, and possibly cheaper, version
of the drug.39 As a result, the manufacturer, who is already at liberty to
set the prices for the drug, can keep the price high and stifle any
competition.
40
In addition to the research and development costs, and the high
costs of patents, drug companies spend substantial sums of money on
advertising and marketing. 4 1  The statistics indicate that drug
companies spend approximately 27% of their revenues on marketing of
their new product. Of the leading nine drug companies, 81% of the
employees comprise the marketing departments of these large
corporations.43 Over the past several years, while the number of
research employees at these companies has declined, the number of
employees devoted to marketing has increased by 59 percent. 44 For
example, in 2001, Merck had "85 percent of its 78,100 employees
engaged in non-research activities. 45
Television has also become a popular medium for advertising
prescription medications.46  Until 1992, the American Medical
34 Id.
35 Rebecca Eisenberg, Patents, Product Exclusivity, and Information Dissemination:
How Law Directs Biopharmaceutical Research and Development, 72 FORDHAM L.
REv. 477, 479 (2003).
36 Id.
37 Id.
38 Rosenfield, supra note 27, at 1051.
39 id.
40 id.
41 Id.
42 Khosravi, supra note 31, at 431.
43 Id.
44 Id.
45 Id.
46 Harris, supra note 21, at 224.
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Association "opposed all direct-to-consumer advertising., 47 The FDA,
which once opposed such advertising to the consumer, recently allowed
drug companies to "unleash waves of advertising on the public., 48 All
of these marketing and advertising statistics clearly show the great
emphasis and money spent on non-research related work, thus driving
up the cost of prescription in the United States.
Several other factors contribute to high drug prices in the
United States. The executive officers of the companies have extremely
high salaries. In 2001, the average income for the top executives at the
leading nine drug manufacturers averaged almost $21 million, not
including stock options held by the executives. 49 Additionally, it is
suggested that drug companies raise the rates to the public to offset the
low cost to the "most favored purchasers., 50  By law, the drug
companies must "give the four largest federal consumers a 24 percent
discount." 51 In addition, the drug companies must sell their product to
Medicaid at a reduced cost. 52 As a result of providing low costs to
others, the drug companies raise the prices to the average consumer,
many of whom are elderly patients on fixed incomes. 
53
D. Canadian Pharmaceutical Regulation
By contrast, the Canadian government, by way of the Patented
Medicines Prices Review Board (PMPRB), heavily regulates drug
prices. 54  Unlike the United States where drug companies can set
whatever price they desire, the Canadian PMPRB compares "a drug's
price to foreign prices of the same drug, domestic prices of similar
drugs, and changes in the Canada Consumer Price Index." 55  The
PMPRB then sets the prices as it deems reasonable based on the
numbers found in the comparison process. 56 The drug manufacturers
are not allowed to set their own prices in Canada; the PMPRB sets the
47 Id.
48 Id.
49 Khosravi, supra note 31, at 431.
50 Id.
51 id.
52 id.
531d.
54 Rosenfield, supra note 27, at 1053.
55 id.
56/d.
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prices without regard to the costs for research and development; thus,
keeping the prices low. 
57
III. THE U.S. FEDERAL GOVERNMENT'S
POSITION ON PHARMACEUTICALS
A. The Food and Drug Administration's Regulations
The Department of Health and Human Services (HHS) is the
governmental agency responsible for oversight of the Food and Drug
58Administration (FDA). In turn, it is the responsibility of the FDA to
regulate all prescription medications in the United States, including
drugs imported from foreign nations.59 Drugs are regulated by the
FDA under the Federal Food, Drug and Cosmetic Act.60 To be sold to
the American public, prescription drugs must first gain FDA
61
approval. Manufacturers, in attempting to obtain approval, must file
a New Drug Application with the FDA.62 Clinical and pre-clinical
studies, indicating the safety and efficacy results, must be included with
the application.
63
Upon receipt of the application materials, it is the duty of the
Secretary of the Treasury to deliver the imported drugs to the Secretary
of Health and Human Services for proper safety and packaging
review. 64 The Secretary hears testimony on the imported material and
determines if the import is safe under the agency's standards. 65 If the
Secretary determines that the imported establishment is not fit for
consumption in the United States, the Secretary of the Treasury may
66destroy the article or have the article exported.
The FDA also prohibits the re-importation of drugs originally
manufactured in the United States, unless re-imported by the
57 Id.
58 Ludmila Bussiki Silva Clifton, Internet Drug Sales: Is It Time to Welcome "Big
Brother" Into Your Medicine Cabinet?, 20 J. CONTEMP. HEALTH L. & POL'Y 541,
556 (2004).
59 Id.
60 21 U.S.C. § 301 (2000).
61 Syntex v. InterPharm, No. CIV.A.:92-CV-03HTW, 1993 WL 643372, at *1
(N.D.Ga. Mar. 19, 1993)
62 Id.
63 id.
64 21 U.S.C.A. § 381(a) (2000).
65 Id.
66 Id.
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manufacturer. 67  However, "in certain circumstances, the Food and
Drug Administration does allow a person to import prescription drugs
to the U.S. for personal use." 68  The FDA may permit citizens to
"import up to a 90-day supply of a drug that isn't approved in the U.S.
if the drug is for a serious condition and isn't likely to cause harm."
69
Most Americans, however, do not fall within this exception category,
and consequently, are not permitted to legally import lower cost
prescription drugs.70
The FDA states that the primary reason for prohibitin
importation of prescription drugs from foreign countries is safety.W
The FDA mandates that all drugs be inspected by the agency to ensure
quality.72 The FDA claims that it cannot start inspecting the cheaper
imported drugs because "it lacks the money to add a multitude of new
sources to its inspection programs. 73
In addition to regulating safety and efficacy, the FDA regulates
the packaging of drugs and determines if the imported drugs meet the
packaging requirements, including the requirement that there be an
insert explaining the drug's composition and use. 74 The FDA requires
that drugs be held in specific storage conditions75 and be packaged "to
arrive in designated dosages with the approved patient package
inserts. 76
The FDA's prohibition of imported drugs has not, however,
deterred the American public from going to great lengths to save
money on their prescriptions. Individuals often purchase their drugs
directly from Canadian pharmacies, by crossing the border, or via the
internet without FDA intervention.77  Last year, for example,
"Americans spent about $1 billion on drugs from Canada" and the
67 21 U.S.C.A. § 381(d)(1) (2000).
68 Tara Parker-Pope, Health Mailbox, WALL ST. J., July 27, 2004, at D5.
69 Id.
70 Id.
71 Regulatory Issues; FDA Rejects Illinois Drug Import Pilot Program, BIOTECH LAW
WEEKLY, July 2, 2004, http://www.newsrx.com/newsletters/Biotech-Law-
Weekly/2004-07-02/06282004333999BL.html [hereinafter Regulatory Issues].
72 Kris Hundley & Stephen Nohlgren, Global Drug Shuffle May Backfire, ST.
PETERSBURG TIMES, Oct. 7, 2004, at IA.
73 Id.
74 Rx Depot, 290 F.Supp.2d at 1242.
75 Id. at 1241.
76 Id. at 1242.
77 Politics & Policy Reimportation: Savings Would Be Negligible, HHS Says,
AMERICAN POLITICAL NETWORK, AMERICAN HEALTH LINE, Dec. 22, 2004, available
at 12/22/2004 APN-HE 2 [hereinafter Politics & Policy Reimportation].
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figures continue to rise.78  The FDA, while stating that such
importation is illegal, concedes that it is "impossible for the agency to
police the millions of packages mailed to consumers from Canada., 79
As such, Americans continue to spend millions of dollars buying
prescription drugs from Canada, regardless of the practice's illegality.8
B. Presidential Views of Re-importation
The cost of health care in the United States has been a central issue in
recent presidential elections. In 2000, President Bush vowed to enact a
Medicare prescription drug plan.81 In 2004, President Bush continued
to campaign on health care reform, stating that he intended to "expand
health savings accounts and enact medical liability reforms" to control
the cost of health care in the United States.
82
Despite strong public support for re-importation of prescription
drugs, President Bush consistently noted that the ban on re-importation
of prescription drugs should not be lifted due to concern surrounding
the safety of the imports. 83 President Bush hinted during the 2004
campaign that he mayL consider re-importation if the safety of such
drugs can be ensured. However, recent reports indicate there are no
plans to decrease drug costs through re-importation methods.85 The
HHS task force stated that "the cost of establishing a system to assure
78 Hundley & Nohlgren, supra note 72.
79 Parker-Pope,supra note 68, at D5.
80 Hundley & Nohlgren, supra note 72.
81 Election 2004: Bush Promotes New Medicare Rx Benefit, Criticizes Kerry Plan,
AMERICAN POLITICAL NETWORK, AMERICAN HEALTH LINE, Nov. 2, 2004, available
at 11/2/2004 APN-HE 2 [hereinafter New Medicare Rx Benefit].
82 id.
83 Id.
84 Id.; see See MINORITY STAFF COMMITTEE ON GOVERNMENT REFORM, U.S. HOUSE
OF REPRESENTATIVES, FACT SHEET: ENACTMENT OF REPUBLICAN DRUG IMPORT
LEGISLATION IN 2000 FAILED TO REDUCE DRUG PRICES FOR UNINSURED SENIORS 1,
http://www.democrats.reform.house.gov/Documents/20040628105404-88449.pdf
(last visited Feb. 6, 2006) [hereinafter REPUBLICAN DRUG IMPORT LEGISLATION]..
President Bush, during the 2000 presidential debates, stated that the Medicine Equity
Drug Safety Act (MEDSA) "made sense" because it lowered the cost of prescriptions
for America's seniors. Id.
http://www.democrats.reform.house.gov/Documents/20040628105404-88449.pdf
(last visited Feb. 5, 2006).
85 Leah Carlson, Drug Importation Dealt Setbacks, EMPLOYEE BENEFIT NEWS, Feb. 1,
2005, http://www.benefitnews.com/detail.cftn?id=7032 (last visited May 3, 2006).
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the safety of imported pharmaceuticals outweighs the public
benefits."
6
Polls consistently indicate the public's interest in reforming
health care and prescription drug coverage is an important component
of a reformation. 87  In lieu of supporting the re-importation of
prescriptions, however, President Bush has acted on his 2000 campaign
promise by instituting the Medicare Prescription Drug, Improvement,
and Modernization Act of 2003 which takes effect January 1, 2006.88
The prescription drug plan, known as Medicare Part D, is intended to
lighten the cost to the elderly and disabled citizens purchasing
prescriptions. 89 The insured members have two options for purchasing
their prescriptions: a fee-for-service option or "a managed care plan
with a drug benefit." 90 Under the Part D plans, the Medicare recipient
pays the first $250 toward the costs of prescription medications in a
given year.91  Once this $250 deductible is met, the insured is
responsible for "25 percent co-insurance for costs above the deductible
up to the initial limit, which is $2,250 in 2006. "92 Once the initial $2,
250 is satisfied, the insured is responsible for paying "all drug costs
until the enrollee has $3,600 in out-of-pocket expenses for covered
drugs, which equates to $5,100 in total expenditures." 93 Once the
Medicare beneficiary has paid the $3,600 out-of-pocket cost,
"catastrophic coverage begins and the Medicare Part D plan will pick
up approximately 95 percent of future costs."
94
President Bush called the Medicare Plan D "the greatest
advance in health care coverage for America's seniors since the
86 d. The task force found that legalizing the importation of prescription drugs would
only produce small savings for Americans, would interfere with the development
process of new drugs, and would only increase the regulatory costs of the federal
government. Id. This report has drawn criticism from some members of Congress,
including Sen. Byron Dorgan, Democrat-North Dakota and Sen. Olympia Snowe,
Republican-Maine, who called the report a "disappointment." Id.87 Imported Drugs, supra note 18.
88 Headaches for All, supra note 8. See Omnicare.com, Benefit Description,
http://www.omnicare.com/mma-desc.asp.
88 Omnicare.com, Benefit Description, http://www.omnicare.com/mma-desc.asp (last
visited Feb. 5, 2006).
89 d.
90 Omnicare.com, Benefit Description, http://www.omnicare.com/mma-desc.asp.
91 Headaches for All, supra note 8.
92 Omnicare.com, Benefit Description. http://www.omnicare.com/mma-desc.asp.
93 Id.
94 Id.
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founding of Medicare." 95  However, the plan has been labeled
"complicated" and is expensive, with estimated costs hovering over
$700 billion.96  Additionally, the plan does very little to lift the
importation ban on cheaper prescription drugs from Canada. 97 Rather,
the focus of the Medicare Act is to lower health care costs by other
means. 
98
Recently, however, President Bush stated that it will remain
illegal to import prescription drugs from foreign countries. 99 Safety is
the reason most commonly stated for declining the requests to import
prescriptions.100  To ensure such medicine is safe for public
consumption, the President's administration argues that it may cost the
government "several hundred million dollars a year."
10
'
Additionally, President Bush's administration states that
legalizing the importation of prescription drugs would "probably have
an adverse effect on the future development of new drugs for U.S.
consumers." 102 The President's task force evaluating the situation
states that importation of prescription drugs would "slow the flow of
new drugs and ultimately resulting in four to 18 fewer drugs being
introduced each decade."' 3 The result of the reduction in new drugs,
the task force claims, would be a "substantial cost to society."'
°0 4
In addition to his Medicare plan, Bush advocates purchasing
generic drugs as a means for curbing high prescription costs."0 5 The
Bush administration argues that prescription medicines can be
purchased at lower cost by simply buying the generic substitute.' 06
The investigative task force states that by buying the generic products,
the savings to the public would approximate $17 billion per year.107
95 Harris, supra note 21, at 234.
96 Headaches for All, supra note 8.
97 Harris, supra note 21, at 234.
98 Id.
99 Imported Drugs, supra note 18.
100 Robert Pear, Administration Offers a Mixed View on Drug Imports, N.Y. TIMES,
Dec. 22, 2004,at A28.
101 Id.
102 id.
103 Politics & Policy Reimportation, supra note 77.
104Id.
105 Id.
106 Id.
107 id.
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C. Congress' Stance and Efforts On Re-importation
1. Recent History of Congressional Efforts
For many years, Congress staunchly supported the FDA's conservative
decision to prohibit the importation of prescription drugs.' 08 However,
in the past 20 years, Congress has altered its view, as "consumer
sovereignty has come to dominate consumer protection in the political
discourse of product regulation."' 10 9  Today, the FDA is often
"criticized as a paternalistic bureaucracy imposing costly regulatory
barriers between patients who demand new products and an industry
eager to deliver these products.""
0
Recent Congressional efforts to control rising pharmaceutical
prices included the International Drug Parity Act of 1999 (IDPA)"' 1
and the subsequent Medicine Equity and Drug Safety Act of 2000
(MEDSA) 112 The IDPA was written to allow access to cheaper drugs
by expanding the United States-Canadian pharmaceutical market."
3
However, the IDPA was not signed into law despite being popular in
Congress. 114
IDPA was important despite its defeat, however, because it laid
the groundwork for MEDSA, which allowed for the re-importation of
American-made, FDA-approved drugs." 5 MEDSA was broader than
its predecessor, the Prescription Drug Marketing Act, which only
permitted re-importation of products from FDA-regulated
pharmaceutical manufacturers. 16
In October 2000, recognizing the rising cost of prescription
drugs, the Medicine Equity Drug Safety Act (MEDSA) was passed by
Congress and was signed into law by President Clinton." l 7 The plan
was designed to lower the cost of prescriptions "by allowing drug
wholesalers to import lower-priced drugs from foreign countries.'
However, the then-Secretary of Health and Human Services, Donna
108 Eisenberg, supra note 35, at 487.
109 Id.
1101Id.111 Harris, supra note 21, at 230.
112Id.
114 id.
115 Id.
116 Harris, supra note 21, at 230.
H7 Id. at 231. See REPUBLICAN DRUG IMPORT LEGISLATION, supra note 84, at 1.
118 REPUBLICAN DRUG IMPORT LEGISLATION, supra note 84, at 1.
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Shalala, and the more recent Secretary Tommy Thompson, never "took
steps to promulgate the regulations permitted by MEDSA." l 9  The
Secretaries stated that health concerns regarding the re-importation of
drugs kept them from broadcasting MEDSA. 120
2) Senator's Direct Efforts to Constituents and Views of
Presidential Efforts
With no current universal legislation being followed, Senators
throughout the country have made an effort for their state constituents
to purchase drugs from Canada in an effort to save their citizens
significant sums of money. Vermont Senator Bernard Sanders, for
example, assisted in organizing a bus tour to Canada for the specific
task of purchasing lower-cost prescriptions.1 21 Similarly, Senators
Stabenow of Michigan and Johnson of South Dakota scheduled trips
across the border with constituents to purchase drugs at a significantly
reduced rate. 122 Lowering the cost of prescription drugs, despite the
views of the President and some Congressional members, continues to
be a bi-partisan effort in Congress. 123  Congress has stated that
President Bush's view on importation is too narrow and that he has
made little effort to solve the cost crisis. 124 Congressional members
consistently speak out on the issue, arguing that individuals regularly
import prescriptions for personal use without any safety issues
arising.125 As Senator Byron Dorgan (D - N.D.), pointed out? during
the recent flu vaccination shortage, the federal government purchased
flu vaccinations from abroad without concern.1 26  As such, many
members of Congress support the importation of prescription
medications.
19 Harris, supra note 21, at 231.
1
2 0 
id.
121 Khosravi, supra note 31, at 427.
122 id.
123 Pear, supra note 100.
124 Politics & Policy Reimportation, supra note 77.
125 id.
126 Id.; see Prescription Drugs; U.S. FDA Says Adding States to I-SaveRx Expands
"Risky" Program, HEALTH & MEDICINE WEEK,
http://www.newsrx.com/newsletters/Health-and-Medicine-Week/2005-01-
10/0110200533313085W.html [hereinafter Prescription Drugs]. In addition to
Illinois, other states and cities, including New Mexico, New York City, and
Cleveland,obtained approximately 700,000 doses of the flu vaccine from European
suppliers. Id.
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There is support for legalization of re-imported medicine from
both political parties in Congress.127 Members of Congress note that
President Bush's Medicare Prescription Drug Plan may adversely affect
retired individuals. 128  The Congressional Budget Office states that
these individuals face losing their health care coverage from their
former employers, because the employers may feel that since Medicare
has instituted a plan, there is no longer a need for them to supply their
former employees with continued health insurance and prescription
drug coverage. 29
Congress attributes the lack of action towards importation to the
President's special interest in the pharmaceutical industry.' 30  Senate
Democrats have argued that the Bush administration will not entertain
the idea of drug importation because of the substantial "desire to
protect the United States' drug companies' highly profitable domestic
market."' 13 1  Similarly, Senator Dorgan states that "the only thing
endangered... is the incredibly large profits from the drug
companies."132 Despite criticism for President's Bush's stance and the
strong support in Congress for legalizing re-imported prescriptions, the
House Majority Leader, Tennessee Republican Bill Frist, has "brushed
aside any time for legislation allowing the freer import of prescription
drugs from Canada"' 13 3 and "has blocked a vote on the legislation in the
Senate." '34
Despite federal support for drug importation, the FDA has
attempted to curb importation by litigating against private companies
importing prescriptions. The private causes of action discussed below
may signal a dismal future for state-sponsored drug importation
programs that will be discussed in Section V.
127 id.
128 Headaches for All, supra note 8.
129 id.
130 Id.
131 New Medicare Rx Benefit, supra note 81
132 Politics & Policy: Re-importation Savings Would be Negligible, HHS Says,
American Political Network, American Health Line, Vol. 10, No. 9, Dec. 22, 2004,
available at 12/22/2004 APN-HE 2.
133 David Rogers, As Election Looms, Republicans Trim Their Legislative Agenda,
WALL ST. J., Sept. 9, 2004, at A4.
134 Politics & Policy Reimportation, supra note 77.
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IV. LEGAL ACTION AGAINST PRIVATE
IMPORTERS
Most recently, the FDA has focused its efforts "on stopping
commercial entities from importing prescription drugs"'13 5 rather than
interfering with the state programs. Legal action has already been
taken against two private entities regarding the re-importation of
prescription medications. There are two prominent cases on this issue:
Syntex v. InterPharm 136 and U.S. v. Rx Depot. 
137
A. Syntex v. InterPharm
InterPharm was an international pharmacy, which imported
medications from Europe and Canada.' 38 The imported goods satisfied
U.S. standards for medications.' 39 Interpharm advertised throughout
the United States via magazines and direct mailing.140  Customers
could order the medications by calling the company directly or by mail
order upon furnishing a prescription from a physician. 14 | Interpharm
advertised that if the drugs were being imported for personal medicinal
uses, the FDA ban on importation did not apply to these consumers.142
The company originally sold two generic pharmaceutical products;
however Interpharm later expanded their product line to include generic
forms of naproxen and naproxen sodium -- drugs that directly
competed with the plaintiffs FDA approved drug. 1
43
The plaintiffs introduced evidence that Interpharm was
importing medications without the approval of the FDA.14 The court
held that because the drugs being sold by Interpharm were available in
the United States, the FDA exception to importation did not apply. 145
The court enjoined InterPharm from selling drugs that were available in
135 Prescription Drugs, supra note 126.
136 Syntex, 1993 WL 643372 (N.D.Ga. Mar. 19, 1993).
137 Rx Depot, 290 F.Supp.2d at 1238.
138 Syntex, 1993 WL 643372, at *1.
139 id.
14 0 id.
141 Id.
142 id.
143 Syntex, 1993 WL 643372, at *1
144 id.
145 Id.
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the United States and misrepresenting to the public that individual
importation of medications does not violate the FDA code. 146
B. U.S. v. RxDepot
In U.S. v. Rx Depot and Rx of Canada, the defendants, collectively
known as Rx Depot, were incorporated in Nevada and engaged in the
importation of pharmaceuticals. 147  The corporation operated
approximately 85 stores in the United States with an 800 customer per
day base. 148
Rx Depot customers could obtain prescriptions from Canadian
pharmacies by submitting the required forms to Rx Depot and
furnishing a physician's prescription. 14 9 Once this information was
received, a Canadian physician re-wrote the prescription, which was
then filled by a Canadian pharmacy. 150 The pharmaceuticals were then
shipped to the customer in the United States.
The defendants received notification that they were engaged in
the illegal practice of importing "U.S.-manufactured and unapproved
foreign-manufactured prescription drugs from Canadian pharmacies to
U.S. citizens."' 152 Rx Depot, however, continued this practice despite
the warning. 153 Rx Depot even o ened more stores throughout the
country in defiance of the warning.
Discovery in the case revealed flaws in the system. 155 Contrary
to defendant's claim, the amount of prescription shipped to the
customer was often greater than the amount prescribed by the
physician. 15 6  In one instance, an undercover agent falsified a
prescription for an anti-depressant and ordered the medication from the
Rx Depot website. 157 The counterfeit prescription was written for 60
pills.' 5  However, the agent was able to order a 100-pill supply from
146 id.
147 Rx Depot, 290 F.Supp.2d at 1240.
148 id.
14 9 Id. at 1241.
150 Id.
151 Id.
152 Rx Depot, 290 F.Supp.2d at 1241.
153 id.
154 Id. at 1244.
151 Id. at 1242.
156 id.
15' Rx Depot, 290 F.Supp.2d at 1242.
158 id.
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Rx Depot and ultimately received a 99-pill supply of a foreign version
of the anti-depressant he ordered.' 59
The court held that Rx Depot violated 21 USCA §381(d)(1),
known as the Federal Food, Drug, and Cosmetic Act.' 60 The court held
that Congress and the FDA must be the forum in which to regulate re-
importation in order to ensure the safety of the medications.' 6 ' The
court stressed that the prohibition on the re-importation of prescriptions
is designed to decrease the risk of "counterfeit, adulterated,
misbranded, subpotent, or expired drugs" being sold to the American
public. 162
The court, however, sympathized with consumers due to the
high prices paid for prescriptions. 163 It noted that studies show that the
United States "ranks significantly higher than other countries, including
Canada, in terms of prescription drug costs."'' 64  Nevertheless,
according to the court, importation is prohibited by law and low-costs
should not be the result of illegal activity.' 
65
V. STATE IMPORTATION PROGRAMS
In response to the continued ban on importation of lower costs
pharmaceuticals, states have taken steps to lower the cost of
prescriptions for their citizens. 166 For example, Minnesota used the
internet to educate consumers about imported prescription drugs and to
offer consumers "information about state-approved Canadian
pharmacies."' 167 Under the Minnesota plan, European pharmacies are
not used and Canadian pharmacies are the citizens' only option for re-
importation.168 Additionally, the plan seeks merely to educate citizens
of Minnesota about importation from Canada; the state is not directly
involved in importing prescription medications for consumers.69
159 Id.
160 Id. at 1246.
161 Id. at 1245.
162 Rx Depot, 290 F.Supp.2d at 1248.
163 id.
'64Id. at 1244.
165 Id. at 1248.
166 Helkei Tinsley, Prescriptions Without Borders: America Looks to Canada for
Answers to Solve the Prescription Drug Pricing Predicament in the U.S., But is
Importation Really the Solution?, 25 HAMLINE J. PUB. L. & POL'Y 437, 468 (2004).167 Id.
168 id.169 id.
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Minnesota created a website for educating citizens of the state
about the Canadian pharmacies. 170  On this website, consumers can
view a list of the approved Canadian pharmacies, compare the prices of
prescription medications, and learn about "cost saving strategies."' 17 1
The consumer can also fill their own prescription by contacting the
pharmacy directly with their order.' 
72
The Minnesota plan has been praised for focusing on educating
the consumer rather than simply focusing on buying cheap drugs. 1W
Naturally, the big money pharmaceutical companies have not given the
Minnesota plan such a warm reception.' 74 Wanda Mobius, the director
of communications for the Pharmaceutical Researchers and
Manufacturers of America (PhRMA), stated that Minnesota's plan
"opens the door to one of the fastest growing crimes-Intemet
scams," 175 and that Minnesota's plan acts to "jeopardize the safety and
stability of life saving pharmaceuticals.'
76
Drug companies have taken matters into their own hands in
response to programs such as the Minnesota plan. 77 Many companies
are limiting the supply of pharmaceuticals to Canada, "have changed
their contractual terms with Canadian pharmacies, and bullied their
way into regulating Canadian pharmaceutical sales to Americans. ' 7 8
Pfizer and GlaxoSmithKline (GSK) are two such examples. Pfizer no
longer supplies Canadian pharmacies known for exporting
medications. 179 Additionally, Pfizer, along with other pharmaceutical
companies, have allegedly raised their prices for purchases made by
Canadian pharmacies. 180 The pharmaceutical manufacturers argue that
they have the right to do this in order to prevent American citizens from
violating the law. However, contrary to what the pharmaceutical
companies believe is their right, "there has never been any legislative
history or case law to support the idea that companies may violate
antitrust laws in order to uphold import laws."' ' 8 1
170 id.
17' Tinsley, supra note 166, at 469.
172 id.
171 Id. at 472.
174 Id. at 473.
171 Id. at 474.
176 Tinsley, supra note 166, at 474.
177 id.
178 Id.
179 id.
180 Id. at 474-475.
181 Tinsley, supra note 166, at 476.
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VI. ILLINOIS' IMPORTATION PROGRAM
A. Logistics of the I-SaveRx Plan
The previous discussion focused on the quashed efforts and cool
reception to importing prescription drugs from lower-priced foreign
markets. However, Illinois' Governor Rod Blagojevich forged ahead
and enacted an Illinois prescription drug plan called I-SaveRx. 8 2 In
this section, the plan will be discussed and its viability analyzed.
Unlike the Minnesota plan, which serves to merely educate the
consumer and not actively participate in the importation process, the
Illinois plan contracts "with a pharmacy-benefit manager to establish a
list of pharmacies and wholesalers in Canada, Ireland, and the U.K."'1 83
The pharmacy-benefit manager, hired by the state, will "oversee as
many as 50 pharmacies, ' 84 and will provide medications to enrolled
citizens. 185
Governor Blagojevich's aggressive plan is in response to the
noted need for lower cost prescription drugs and the failure of the
federal government to act. 86 Illinois officials estimate that "2.8
million of the 12.6 million residents in Illinois do not have prescription
drug coverage'0 87 in a time when prescription drug costs are up over 17
percent. 1
88
The I-SaveRx plan is available to all Illinois residents,
regardless of their economic status.' 89 Residents register via the
internet or over the telephone.190 Prospective registrants must fill out a
182 I-SaveRx.net, Frequently Asked Questions, http://www.i-saverx.net/general.htm
(last visited Feb. 19, 2005).
183 Anna Wilde Mathews,,Illinois to Set Up a Program To Promote Drug Importation,
WALL ST. J., Aug. 17, 2004, at D4. See Prescription Drugs, supra note 126 (stating
that Illinois I-SaveRx officials are also contemplating using additional countries as
sources for drugs if Illinois is unable to use the current countries associated with the
program).
184 Illinois Program to Help Residents Buy Prescription Drugs from Canada or
Europe (National Public Radio: All Things Considered radio broadcast Aug. 17,
2004) [hereinafter NPR].
185 Mathews, supra note 184.
186 Sweet, supra note 5.
187 Id.
188 Harris, supra note 21, at 219
189 Sweet, supra note 5.
190 Id.
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detailed medical profile. 191 Customers must then have the physician
fax the prescription to the Canadian clearinghouse or the original
prescription must be mailed in by the customer. 192 Once this process is
complete, the residents can contact the Canadian clearinghouse to
compare prices of medications, check availability and purchase refills
of their prescription drugs. 1
93
Illinois officials state that the program could greatly help
consumers by offering prescription drugs at 25 percent to 50 percent
savings. 194 Governor Blagojevich estimates that if all of the 2.8 million
people in Illinois without drug coverage registered for and used the I-
SaveRx plan, the savings would be approximately $812 million.' 95 If
only 100,000 people participated, the savings would still be an
impressive $29 million.'1 96
Not surprisingly, the FDA, given its conservative stance on
importation, is not in favor of the new Illinois plan."' The FDA
originally denied the state support for its pilot drug importation
program. 98 Governor Blagojevich pressed on, however, claiming,
"We can't keep waiting. ' 199  The FDA is aware of the I-SaveRx
program but at this time has not gone to court over the issue.
20 0
B. Will Illinois' I-SaveRx Plan Survive?
Although organizations such as PhRMA have voiced discontent with
states' efforts to educate consumers, 20 legal action has not been taken
because states such as Minnesota are not sponsoring the importation.
Rather, the state is Just offering its citizens information to make
educated decisions. 202  Illinois' plan, however, is different and "heats
up a miniature rebellion" which may invite litigation.20 3
191 Courtney Flynn, Drug Search Turns to Europe, CHI. TRIB., Aug. 17, 2004, at
Metro 1.
192 id.
193 id.
194 Hundley & Nohlgren, supra note 72.
'95 Flynn, supra note 192.
196 id.
197 Hundley & Nohlgren, supra note 72.
198 Sweet, supra note 5.199 Hundley & Nohlgren, supra note 72.
200 id.
201 Tinsley, supra note 166, at 472.
202 Id.
203 Hundley & Nohlgren, supra note 72.
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The Food, Drug and Cosmetic Act only permits manufacturers to re-
import prescriptions. 204 As previously discussed, there is an exception
for personal importation if the drug is for a serious illness, is not
otherwise available to the user, and is not likely to cause serious
harm.205  Additionally, the FDA admits that due to the lack of
resources, it simply cannot crack down on every person importing
prescriptions for their own use.2 °6
As evidenced by Sytex v. InterPharm and U.S. v. RxDepot, the
government is not refraining from prosecuting private import providers.
The question remains whether the states will be prosecuted for their
efforts, too. While Minnesota offers educational materials and links to
companies selling Canadian drugs, the FDA notes that the Illinois plan,
by utilizing pharmacies in the United Kingdom and Ireland, is
increasing "the state aggressiveness in causing the importation of these
products"2 07 and may force the FDA "to go to a federal judge to referee
this matter." 2°8 At present, Illinois aids its citizens in the importation
of prescription drugs for personal use, 209 a method that is currently not
in violation of the law. Illinois is not acting as a "direct importer," a
position that could lead to prosecution.
2 10
The FDA is not limited to using only legal means to terminate
drug importation. Random confiscation of imported drugs has also
occurred. 211 After his medication did not arrive, Charles Netzo, an 81-
year-old man, discovered that the Lipitor he ordered from Canada was
seized by the FDA.212  Such tactics were labeled as forms of
"intimidation" by Illinois Representative Rahm Emanuel.213
Representative Emanuel claims that the FDA has not currently shut
down any state's internet buying program, arguing that if it were truly
214illegal, more action would have been taken. However, this form of
204 21 U.S.C.A. §381 (d)(1) (2000).
205 Parker-Pope, supra note 68.
206 Id.
207 Flynn, supra note 192.
208 Id.
209 Hundley & Nohlgren, supra note 72.
210 CMS Could Refuse Medicaid Approvals for Rx-Importing States, FDA WEEK, Dec.
10, 2004, available at 2004 WLNR 13678857 [hereinafter Medicaid Approvals].
211 Interview by Katie Couric with Representative Rahm Emanuel (NBC News:
Today broadcast Feb. 8, 2005) (discussing FDA seizures of prescription drugs
imported from Canada).2 12 id.
213 Id.
214/id.
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direct detention of prescriptions indicates the lengths to which the FDA
will go to prohibit drug importation.
2 15
The FDA is not, however, the only organization that may halt
the Illinois plan. Should Illinois begin directly importing drugs, it
could face retribution from the Centers for Medicare and Medicaid
Services (CMS). 216 All states are required to have their Medicaid plans
approved by CMS, 2 17 and CMS could simply not approve a state's plan
if it contains re-importation provisions.218 Therefore, it is clear that the
CMS has a much more simple method to keep states from importing
drugs, whereas the FDA would have to "sue states to stop them from
importing drugs, which would be a long, expensive process." 219 This
issue arose in Michigan several years ago, when the state dropped its
re-importation plan because it needed to have its Medicaid plan
approved.220
Canada, itself, may quash Illinois' efforts to import prescription
drugs.221 While approximately two-thirds of the pharmacies used in the
Illinois plan are based in Europe, the Canadian pharmacy CanaRx is
handling the program.222  Due to the high demand for lower-cost
prescription drugs from Canada, many of the Canadian suppliers feel
strained and cannot accommodate all of the importation requests.
22 3
The inability to handle the requests may, logically, lead to a shortage in
imports for residents participating in the Illinois plan.
Additionally, Canadian Health Minister Ujjal Dosanjh indicated
224that he may shut down internet pharmacies. Stressing the
importance of ethics and the need to maintain appropriate levels of drug
availability to Canadian citizens, Dosanjh stated that he may be forced
to consider shutting down internet pharmacies in order to keep the
Canadian supply of prescription drugs healthy.
225
2 1 5 
Id.
2 16 Medicaid Approvals, supra note 211 .
217 id
218 id.
2 1 9
/d.
220 Id.
221 Regulation of Pharmaceutical Imports-Take Action, Yet Strike a Balance, For
Importation of Prescription Drugs, ALLENTOWN MORNING CALL, Dec. 7, 2004, at
A 10 [hereinafter Pharmaceutical Imports].
222 Hundley & Nohlgren, supra note 72.
223 Pharmaceutical Imports, supra note 222.
224 Carlson, supra note 85.
225 Id.
1282 [VOL.9.3:1261
ILLINOIS PRESCRIPTION DRUG PLAN
Canada has also considered other methods to curb drug
exportation to U.S. consumers. The Canadian government is
considering forbidding Canadian physicians from "countersigning U.S.
prescriptions, limiting prescriptions' fills to Americans who are
physically in Canada, and creating a list of drugs banned from export
due to supply concerns. 226
The threat from Canada to curb or eliminate the exportation of
prescription drugs to U.S. consumers has not gone unnoticed by
governors helping to import prescriptions. Seeing the possible
detriment to the Illinois I-SaveRx program, Governor Blagojevich sent
a letter to President Bush asking him to "discourage Canada from
prohibiting selling cheaper prescription drugs to Americans. 227 The
Bush administration has staunchly opposed re-importation and
persuading Canada to continue to export to U.S. citizens is highly
unlikely. 228 Other governors sent letters directly to the Canadian Prime
Minister "urging him not to restrict Canadian prescription drug sales to
229U.S. consumers.
VII. CONCLUSION
In recent years, American citizens have seen drug prices increase at
approximately eight times the rate of inflation. 230 Simultaneously,
fewer Americans are able to afford health insurance, 231 and fixed
incomes have not kept up with the rising drug costs. 232 As a result,
more people and state governments are searching for ways to purchase
drugs from abroad where the average cost is 20 percent to 80 percent
less.233 While other states supply their citizens with websites and
educational information,234 the Illinois program enables residents to
purchase prescriptions through state-sponsored Canadian
226 Id.
227 Two Governors Complain to President Bush About Canadian Drugs, DRUG WEEK,
Jan. 28, 2005, available at 2005 WLNR 820758..
228 id.
229 Governors Urge Canada Not To Restrict Drug Importation, FDA WEEK, Feb. 4,
2005, available,at 2005 WLNR 1570384. Six state governors wrote to the Canadian
Prime Minister, including governors of Minnesota, Utah, Maine, Wisconsin, Kansas,
and North Dakota; Illinois Governor Rod Blagojevich did not write to the Canadian
official. Id.
230 Tinsley, supra note 166, at 442.
231 Headaches for All, supra note 8.
232 Regulatory Issues, supra note 71.
233 Pharmaceutical Imports, supra note 222.
234 Tinsley, supra note 166, at 472.
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clearinghouses. 235 This is process has been called "clearly illegal" by
some FDA officials; however, no legal action against the state has thus
far been taken. 236 Illinois faces an uphill battle, however, and appears
to be skating on thin ice. While the FDA currently has not sued the
state, the time may come when Illinois faces off with the federal
government over the issue of importation of foreign drugs.2 37 Given
the power of the pharmaceutical companies, the FDA's lobbying
efforts, the possible threats from the CMS, and Canada's own tactics to
decrease drug supply to the United States, the prospects for Illinois' I-
Save Rx plan do not look promising. While drug importation is
beneficial because it can offer citizens lower cost prescription drugs, it
is not the answer to providing citizens with better pharmaceutical
prices. A strong pharmaceutical lobby and a federal government
willing to litigate the matters impedes the success of state importation
plans. Other avenues must therefore be explored to offer citizens
lower-cost drugs. In my opinion, therefore, the real problems to be
addressed lie with the state of health care in the United States and in the
pharmaceutical industry. Better health insurance plans are needed to
guarantee access to prescriptions. Additionally, the government should
establish a system of regulation, similar to the Canadian method, to
ensure that prices are set fairly and money is spent responsibly at the
leading pharmaceutical manufacturers.
235 Sweet, supra note 5.
236 Id.
237 id.
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